Literature DB >> 23138323

[Pharmacological profiles and clinical roles of 5-azacitidine (Vidaza(®) for injection 100 mg) for the treatment of myelodysplastic syndrome (MDS)].

Yukari Takahashi, Sachie Kimura, Masahiko Okano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138323     DOI: 10.1254/fpj.140.235

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


× No keyword cloud information.
  1 in total

1.  5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene.

Authors:  Ru Liu; Xiao-Huan Zhang; Kun Zhang; Wei Li; Wen-Jun Wang; Di-Xian Luo; Ling Gao
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.